Incobotulinum Toxin Type A (Xeomin®)

Assessment Status Rapid Review Complete
Drug Incobotulinum Toxin Type A
Brand Xeomin®
Indication For the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults.
Assessment Process
Rapid review commissioned 07/02/2014
Rapid review completed 05/03/2014
Rapid review outcome Full Pharmacoeconomic Assessment Not Recommended